Generic Name and Formulations:
Permethrin 5%; crm.
Various generic manufacturers
Indications for Permethrin:
Adults and Children:
<2 months: not recommended. ≥2 months: massage into skin from head to soles of feet. Remove 8–14hrs later by washing. Usually 1 treatment suffices; if living mites are present after 14 days, retreat. Infants: also treat scalp, temples and forehead. Wash or dryclean bedding and clothing appropriately.
Allergy to pyrethrins, pyrethroids, or chrysanthemums.
Avoid eyes. Pregnancy (Cat.B). Nursing mothers: not recommended.
Pruritus, burning, stinging, tingling, numbness, erythema, rash.
Formerly known under the brand names Acticin, Elimite.
Clinical Pain Advisor Articles
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Tools to Address the Opioid Crisis
- Methamphetamine Use on the Rise in Patients With Opioid Use Disorder
- Operant Learning May Provide More Benefits Than Energy Conservation in Fibromyalgia
- Patterns of Non-Medical Prescription Opioid Use in Adolescents
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- Initial Consultation for Neck Pain May Reduce Opioid Consumption, Healthcare Utilization
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Cannabinoid-Associated Analgesia May Be Mediated Through Modulation of Affective Processes
- FDA Panel Votes in Favor of Abuse-Deterrent Oxycodone Reformulation
- FDA Proposes New Restrictions on Sale of Electronic Nicotine Delivery Systems
- Central Sensitization in Greater Trochanteric Pain Syndrome
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds